Cancer Drugs Are Being Approved Before They Work
Pharmaceutical companies have made billions from cancer drugs that were never proven to actually help patients live longer. That is not a conspiracy theory, it is what the data shows. Through the FDA accelerated approval program, new cancer treatments can reach the market before clinical trials confirm they extend survival, and in some cases those confirmations never come. On top of that, drugs that do show results are often prescribed at doses far higher than patients need, quietly padding Big Pharma profits while patients and insurers absorb the cost. This video breaks down how the fast tracking of cancer drug approvals became one of the most profitable loopholes in modern medicine, what it means for patients making real treatment decisions right now, and why the system has been so slow to change. If you want to understand how cancer treatment and pharmaceutical industry incentives actually intersect, this is a good place to start.
Suppliers
Australia
Love Thyself
Thirty years ago we didn’t have the rates of stress, body complexes, depression, food intolerances, cancer and all the other chronic illness
Switzerland
Medinova AG
Range of pharmaceutical products focusing on therapeutic fields such as dermatology, gynaecology, insomnia, and phlebology. Their portfolio
Australia
Imugene Limited
Imugene is a clinical-stage immuno-oncology company developing a range of new treatments designed to activate the immune system of cancer pa
United States
Q Laboratories
Q Laboratories delivers comprehensive analytical testing and microbiology services across five major industries: personal care, prescription
Mexico
Laboratorios PH&S de Mexico
Laboratorio PH&S manufactures dietary supplements using specialized formulas and supports brands throughout commercialization. The team adap
Articles
Canadian Pharma Capacity Shifts That Change Import Timing
Canada's pharmaceutical manufacturing sector entered 2026 with a utilization rate near 78%, up roughly four points from two years earlier. T
From Overwhelmed Systems to Smarter Care: A Turning Point for Health Care
It no longer takes a crisis to reveal the pressure points in modern health care, they are visible in everyday experiences. Long wait times,
Direct to Consumer Pharmaceuticals
Direct to consumer pharmaceutical models are reshaping how patients access treatment, offering a more streamlined path between manufacturers
Digital Health and Telemedicine
The past few years have pushed digital health from the margins into the center of everyday care. What began as a workaround for distance and
Top 5 Companies in Health and Medical Industry
The global health and medical sector is shaped by a handful of companies whose scale, research capacity, and product diversity influence nea
Videos
French Biotech Turns Fecal Bacteria Into a Cancer Drug
This video looks at how a French biotech firm is developing a cancer care drug based on bacteria from human feces, and why the microbiome ha
Barrière's Vitamin Patch Innovation: A New Era in Supplements
Discover how Barrière, a leading vitamin patch brand, plans to disrupt the supplement industry as it projects doubling its revenue to $10 mi
Why Gen Z Is Turning to Thorne for Wellness Solutions
Thorne has quietly become one of Gen Z’s favorite wellness brands by leaning into trust, quality, and a more thoughtful approach to suppleme
Medical Robots Are Expanding With Advances in Technology
As populations continue to grow older, healthcare systems are increasingly turning to robots across many different medical fields. Progress
The Work That Helped Change Health Care in Bangladesh
Sylvana Quader Sinha, a Bangladeshi American lawyer and entrepreneur, founded Praava Health to meet the urgent need for reliable and high qu